Dialysis Access Treatment Devices – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific dialysis access treatment device market will continue to experience modest growth through 2032 after recovering from the impact of COVID-19. The market will be primarily driven by rising adoption of innovative technologies such as percutaneous AVF for dialysis creation, and DCBs for dialysis maintenance along with the favorable clinical trials results associated these devices. A significant rise in the expanding ESRD population will favor the market growth. However, revenue growth will be limited to some extent due to lack of reimbursement in the region leading to cost constraints, which in turn will hinder the adoption of the premium-priced devices.

This Medtech 360 Report provides high-level market metrics for dialysis access treatment devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region from 2019 through 2032.

Table of contents

Dialysis Access Treatment Devices - Market Insights - Asia Pacific (Supplemental)

Bhavesh Jain

Bhavesh Jain is an associate analyst on the Cardiovascular Medtech Insights team at Clarivate, specializaing in the vascular access device market. Bhavesh holds a Bachelor’s degree in Pharmaceutical Sciences from Dr. H.S Gour University and an MBA in Pharmaceutical Management from the National Institute of Pharmaceutical Education and Research, Mohali.

Contact sales Login to access report

Back to all Medtech Insights reports